TNC and neoplasm: Further research into the molecular mechanisms underlying DIPG tumorigenesis, including the role of Tenascin-C in tumor progression and the influence of H3K27M mutations on oligodendroglial precursor cells, is necessary to identify novel therapeutic targets and improve patient outcomes.